Breaking Down Luxi Chemical Group Co., Ltd. Financial Health: Key Insights for Investors

Curious whether Luxi Chemical Group is a resilient buy or a warning sign for cautious investors? In the first half of 2025 the company posted operating revenue of CNY 14.74 billion, while trailing twelve-month revenue as of 30 Sep 2025 reached CNY 30.10 billion, yet profitability tells a tougher story with H1 net profit at just CNY 763 million - a 34.81% decline year‑over‑year - and TTM net income of CNY 1.48 billion yielding a net margin of 6.82%, even as return on equity sits at 7.88% and TTM diluted EPS is CNY 0.78 (P/E 18.45); on the balance sheet the firm carries total debt of CNY 10.69 billion against cash reserves of CNY 721 million and a worrying current ratio of 0.34, while market valuation metrics and an intrinsic model point to potential upside - all of which we unpack in detail across revenue, profitability, leverage, liquidity, valuation and risk factors to help you decide whether Luxi's growth forecasts and sustainability investments justify the exposure

Luxi Chemical Group Co., Ltd. (000830.SZ) - Revenue Analysis

• Operating revenue (1H2025): CNY 14.74 billion - +5.0% YoY vs. 1H2024.
• Annual revenue (2024): CNY 29.76 billion - +17.37% YoY vs. 2023.
• TTM revenue (as of 2025-09-30): CNY 30.10 billion - +3.82% YoY.
• Workforce: 12,124 employees; TTM revenue per employee: ≈ CNY 2.48 million.
• Market capitalization: CNY 31.06 billion; P/S ratio: 1.03.
• 5-year average revenue growth: 5.1% per year.

• The 2024 jump (+17.37%) outpaced the 5-year average (5.1%), indicating a stronger recent cycle-driven recovery.
• TTM growth of 3.82% and a 1H2025 increase of 5.0% suggest momentum moderating after 2024's spike but remaining positive.
• Revenue per employee (~CNY 2.48M) points to relatively high productivity for a chemical producer of this scale.
• With market cap (CNY 31.06B) slightly above TTM revenue, the P/S of 1.03 implies valuation neutrality - neither deeply discounted nor richly priced relative to sales.

Luxi Chemical Group Co., Ltd. (000830.SZ) - Profitability Metrics

• H1 2025 net profit: CNY 763 million (down 34.81% vs. H1 2024)
• TTM net income (as of 2025-09-30): CNY 1.48 billion; TTM net profit margin: 6.82%
• Return on equity (ROE): 7.88%
• Diluted TTM EPS: CNY 0.78; P/E: 18.45
• TTM operating income: CNY 29.84 billion; TTM gross profit: CNY 3.53 billion
• Net profit margin decline: from 9.20% in 2024 to 6.82% in the TTM (a drop of 2.38 percentage points)

Luxi Chemical Group Co., Ltd. (000830.SZ) - Debt vs. Equity Structure

• Total assets: CNY 35.95 billion
• Total liabilities: CNY 10.14 billion
• Total debt: CNY 10.69 billion
• Cash reserves: CNY 721 million

• The 62.01% debt-to-equity ratio signals reliance on debt but not excessive for an industrial chemical firm where capital expenditure and working capital needs are significant.
• Debt-to-EBITDA of 2.80 is within common covenants/tolerance for investment-grade industrials; indicates manageable leverage given operating cash generation.
• Interest coverage at 10.59 provides a comfortable cushion for servicing interest, reducing near-term default risk from operating volatility.
• Debt-to-free cash flow of 5.54 highlights that, while earnings cover interest well, actual free cash conversion would require multiple years to fully deleverage if no new debt is issued.
• Cash reserves of CNY 721 million versus total debt of CNY 10.69 billion indicate limited immediate liquidity; working capital management and access to credit markets are important.

Luxi Chemical Group Co., Ltd. (000830.SZ) - Liquidity and Solvency

• Current ratio: 0.34 - indicates short-term liabilities substantially exceed current assets.
• Quick ratio: 0.09 - shows minimal liquid buffer (cash & equivalents, receivables) to cover immediate obligations.
• Interest coverage ratio: 10.59 - earnings comfortably cover interest expense (~10.6x).
• Debt-to-EBITDA: 2.80 - EBITDA covers total debt about 2.8 times, a middle-ground leverage level.

• High leverage context: Total debt of CNY 10.69bn versus cash of CNY 0.721bn implies limited liquidity cushion and reliance on operating cash flow or refinancing for near-term obligations.
• Operational resilience: Interest coverage of 10.59x and debt/EBITDA of 2.80x indicate earnings capacity to service debt despite tight current liquidity.
• Balance sheet structure: With total assets of CNY 35.95bn and liabilities of CNY 10.14bn, the computed debt-to-equity of 62.01% signals moderate financial leverage compared to peers in capital-intensive chemical sectors.

For context on corporate direction and governance that may influence liquidity and capital allocation decisions, see: Mission Statement, Vision, & Core Values (2026) of Luxi Chemical Group Co., Ltd.

Luxi Chemical Group Co., Ltd. (000830.SZ) Valuation Analysis

This valuation snapshot synthesizes market multiples, capital structure metrics, and an intrinsic valuation signal to help investors assess relative and absolute value for Luxi Chemical Group Co., Ltd. (000830.SZ).

• TTM P/E: 18.45 - reflects current trailing earnings multiple investors are paying.
• Forward P/E: 16.40 - implies anticipated earnings growth or reduced valuation over the next 12 months.
• P/S: 0.90 - the stock trades below one times annual sales, signaling revenue-based cheapness relative to price.
• P/B: 1.42 - the market values the company at 1.42× its book equity.
• EV/EBITDA: 9.08 - market enterprise valuation per unit of EBITDA, useful for capital structure-neutral comparisons.
• Intrinsic valuation gap: ~24% undervalued - calculated against a present-value model of forecast cash flows / normalized earnings.
• Market cap: CNY 27.23 billion; Enterprise value: CNY 38.57 billion - shows the leverage of debt and minority interests included in EV.

Key implications for different investor types:

• Value investors: A ~24% intrinsic discount plus sub-1× P/S and EV/EBITDA ~9.1x supports a closer look for contrarian buys.
• Growth-oriented investors: Forward P/E (16.40) improves on TTM but still requires confirmation from revenue/EBITDA expansion and margins.
• Income/quality investors: P/B 1.42 suggests limited downside vs. book, but capital intensity in chemicals requires monitoring of ROE and asset turnover.

For context on corporate direction and strategic priorities that could affect future valuation multiples, see: Mission Statement, Vision, & Core Values (2026) of Luxi Chemical Group Co., Ltd.

Luxi Chemical Group Co., Ltd. (000830.SZ) - Risk Factors

• Declining profitability: Net profit margin fell from 9.2% in 2024 to 6.82% (TTM), signaling reduced ability to convert revenue into profit.
• Liquidity risk: Current ratio of 0.34 and quick ratio of 0.09 indicate short-term assets are likely insufficient to cover near-term liabilities.
• Leverage and solvency: Debt-to-equity ratio at 62.01% and total debt of CNY 10.69 billion versus cash reserves of CNY 721 million reflect elevated financial leverage and limited cash buffer.
• Operational deterioration: Net profit declined 34.81% in H1 2025 versus H1 2024, suggesting margin pressure, demand or cost issues.
• Market volatility profile: Beta of 0.48 implies lower historical volatility relative to the market, which may reduce market-driven return variability but does not mitigate fundamental risks above.

• Refinancing and interest-rate exposure: High absolute debt level (CNY 10.69B) with limited cash (CNY 721M) raises refinancing risk and sensitivity to rising borrowing costs.
• Working capital constraints: Very low current and quick ratios point to potential difficulties in meeting supplier, payroll, and short-term obligations without asset sales or external financing.
• Profitability pressure: Continued margin erosion (net margin drop and H1 profit decline) could limit retained earnings buildup and restrict deleveraging capacity.
• Operational/market risks: Lower beta reduces share-price volatility but does not insulate from sector-specific downturns (commodity prices, demand cycles, environmental/regulatory changes).

Luxi Chemical Group Co., Ltd. (000830.SZ) - Growth Opportunities

• Projected financial growth: earnings +8.5% p.a., revenue +8.1% p.a. (next 3 years).
• Sustainability target: reduce greenhouse gas emissions by 30% by 2030.
• R&D investment: $50 million allocated in 2024 to improve product quality and lower production costs.
• International expansion: enter five new countries by end-2024; target +15% YoY export revenue growth.
• Workforce development: $10 million invested in training and development in 2024.
• Customer experience: implement new CRM to raise customer satisfaction by 25%.